严重肝炎复杂化奥尔梅沙坦肠道病变:一个病例报告
Ruyi Tan1, Joshua Haron Abasszade1, Hardesh Dhillon1
1Department of Gastroenterology and Hepatology, Monash Health, Melbourne, VIC, Australia.
Case reports in gastroenterology
|April 26, 2024
概括
奥尔梅沙坦肠道病变可能导致严重的肝损伤. 在患有这种罕见并发症的患者中,停止奥尔梅沙坦药物治疗迅速缓解了症状,并使肝功能正常化.
科学领域:
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
背景情况:
- 奥尔梅沙坦是一种血管激素II受体对抗剂,已知会引起肠道病变.
- 奥尔梅沙坦诱导的肠道病变通常呈现为一种吸收不良的过程,在治疗开始后的几个月到几年.
- 肝脏干扰是olmesartan enteropathy的不常见但潜在的并发症.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K


